Sulfonamides as Selective Oestrogen Receptor Beta Agonists.
Roberts, L.R., Armor, D., Barker, C., Bent, A., Bess, K., Brown, A., Favor, D.A., Ellis, D., Irving, S.L., Mackenny, M., Phillips, C., Pullen, N., Stennett, A., Strand, L., Styles, M.(2011) Bioorg Med Chem Lett 21: 5680
- PubMed: 21885279 
- DOI: https://doi.org/10.1016/j.bmcl.2011.08.041
- Primary Citation of Related Structures:  
2YLY - PubMed Abstract: 
A series of p-hydroxybenzenesulphonamides ERβ receptor agonists were discovered and several compounds identified had excellent selectivity over the related ERα receptor. One of these, compound 11, had an interesting binding conformation determined by X-ray and represents an excellent starting point in the quest for further selective ERβ agonists.
Organizational Affiliation: 
Worldwide Medicinal Chemistry, Pfizer, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK. lee.roberts@pfizer.com